Abstract-In the present study, we determined whether interleukin-2 (IL-2) confers cardioprotection by inhibiting mitochondria permeability transition pore (MPTP) opening. In isolated rat hearts subject to 30 min ischemia and 120 min reperfusion (IR), IL-2 (50 U/ml) decreased the infarct size and LDH release, effects blocked by a selective kappa-opioid receptor antagonist, Nor-BNI ( Keywords-Interleukin-2, heart, ischemia/reperfusion, mitochondria permeability transition pore
I. INTRODUCTION
Ischemic preconditioning (IPC) is a phenomenon in which transient nonlethal period of ischemia increase the resistance to a subsequent prolonged ischemic period [1] . It has been demonstrated that Gi protein coupled receptors (GPCR) mediate cardioprotection of IPC [2] . Kappa opioid receptor (κ-OR) is one of these G-protein coupled receptors [3] . Recently it has been shown that interleukin-2 (IL-2), a member of cytokine family, reduced cardiac injury of the rat heart subject to myocardial ischemia and reperfusion and its effect was attenuated by blockade of κ-OR with Nor-BNI, a κ-OR antagonist, indicating that IL-2 confers cardioprotection via κ-OR [4] .
The mitochondria permeability transition pore (MPTP) is a multiprotein complex formed at the contact sites between the inner and outer mitochondrial membranes [5] . Opening of MPTP causes apoptosis/necrosis, which may eventually lead to cell death [6] . The MPTP has been shown to stay closed during ischemia and only open in the first few minutes of reperfusion [7] ; the latter results in myocardial injury [8] . So inhibition of MPTP opening may be beneficial and in fact it was demonstrated that blockade of MPTP opening conferred cardioprotection of IPC [9] . It is therefore hypothesized that IL-2 may confer cardioprotection by inhibiting MPTP.
II. METHODOLOGY 1) Isolated perfused heart preparation: Hearts from male Sprague-Dawley rats of 250-300 g body weight were excised rapidly and placed in ice-cold Krebs-Henseleit (K-H) perfusion buffer before being mounted on a Langendorff apparatus for perfusion at 37°C with K-H buffer at a constant pressure (100 cm H 2 O). The buffer, that had the following composition (mM): NaCl 118.0, KCl 4.7, CaCl 2 1.25, KH 2 PO 4 1.2, MgSO 4 1.2, NaHCO 3 25.0 and glucose 11.0, was equilibrated with 95% O 2 /5% CO 2 . For hearts subjected to regional ischemia, a silk suture was placed around the left coronary artery to form a snare. The coronary artery was occluded by pulling the snare to produce ischemia. Reperfusion was achieved by releasing the snare.
2) Measurement of the area of risk: For determination of infarct size in hearts subjected to regional ischemia, the coronary artery was re-occluded at the end of the reperfusion period and a solution with 2.5% Evans blue was perfused to delineate the area of risk. Hearts were then frozen and cut into slices, which were then incubated in a sodium phosphate buffer containing 1% w/v 2, 3, 5-triphenyl-tetrazolium chloride (TTC) for 15 min to visualize the unstained infracted region. Infarct and risk zone areas were determined with planimetry by using a software Image/J from NIH and infarct was expressed as a percentage of the risk zone.
3) Determination of myocardial injury by lactate dehydrogenase efflux: The effluent from the isolated perfused heart was collected at 5 min of reperfusion and lactate dehydrogenase (LDH) was spectrophotometrically assayed using a kit purchased from Sigma Chemical Co. LDH activity was expressed as units per liter.
4) Preparation of isolated ventricular myocytes:
Single ventricular myocytes were prepared from the heart of male Sprague-Dawley rats by enzymatic dissociation. Only rod-shaped cells with clear cross striations were used for experiments. 
III. RESULTS

A. Effect of IL-2 on myocardial infarct induced by myocardial ischemia and reperfusion in the presence of a MPTP opener
An infarct size of 43.1±7.7% was induced by 30 min of ischemia and 120 min of reperfusion. The infarct size was significantly reduced when IL-2 at 50 U/ml was administered for two cycles of 5 min each interspersed with a 5 min of drug-free perfusion before ischemia (Fig. 1) . Pretreatment of the heart with Atr (20 microM) blocked the effect of IL-2 on infarction. Pretreatment of the heart with 50 U/ml IL-2 significantly reduced the release of LDH (Fig.  1) , which was blocked by Atr.
B. Effect of IL-2 on the changes of intracellular calcium of isolated ventricular myocytes induced by anoxia and reoxygenation in the presence of a MPTP opener
As shown in Fig. 2 ]i induced by anoxia and re-oxygenation. The effect of both IL-2 were blocked by the κ-OR antagonist, 5 microM Nor-BNI (Fig 2) . When Atr (20 microM) was administered for 25 min before anoxia, effect of IL-2 on electrical stimulated [ (Fig. 2) . 
C. Effect IL-2 on the fluorescence of calcein in the isolated ventricular myocyte subject to anoxia and re-oxygenation
Perfusion with K-H solution for 10 min decreased the calcein signal by 15% while anoxia and reperfusion decreased the calcein signal by 80%, indicating opening of MPTP. In the presence of CsA (0.2 microM), the reduction in calcein signal was only 27%, indicating a marked attenuation compared with the group subject to anoxia and re-oxygenation.
Pretreatment of the myocyte with IL-2 at 50 U/ml also attenuated the decrease of the calcein signal induced by AR (Fig. 3) . After incubation the myocytes with Nor-BNI (5 microM) for 10 min, the effect of IL-2 was attenuated. 
IV. DISCUSSION
The main observation of the present study was that κ-OR stimulation with IL-2 conferred cardioprotection, inhibited opening of the MPTP and attenuated alterations of [Ca 2+ ]i, effects also produced by an inhibitor of the opening of MPTP, cyclosporin A. Opening of the MPTP with a pore opener reversed the effects. These are the first evidence that cardioprotection of κ-OR stimulation by IL-2 involves the inhibition of opening of MPTP. Since κ-OR has been shown to mediate cardioprotection of preconditioning with ischemic insults, the finding supports an important role of inhibition of MPTP in cardioprotection of ischemic preconditioning as shown previously [10] .
In the present study we observed that inhibition of opening of MPTP by IL-2 or by the inhibitor of MPTP, that conferred cardioprotection, also attenuated the [Ca 2+ ]i overload particularly during reperfusion, a period when severe cardiac infarction and arrhythmia occur [11] . homeostasis, impaired by ischemia/reperfusion, which is in agreement with our present understanding.
V. CONCLUSION
In conclusion, the present study has provided the first evidence that IL-2 confers cardioprotection by inhibiting the opening of MPTP.
